The treatment of NSCLC cells with VEGFq resulted in significantly decreased VEGF expression, altering the downstream pathways which play important roles in tumor cell behavior, including proliferation/survival and invasion, most likely via blocking the autocrine-loop, but have minimal effects on non-transformed cells. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.